Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2026-01-02 @ 6:14 AM
Study NCT ID:
NCT07223203
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-22
First Post:
2025-10-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Sponsor:
Alnylam Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALN-TTRSC04-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None